TNF and psoriasis: Results suggest that the anti-inflammatory activity observed following exposure of hPBMCs to naringin and sericin (24 h) could be via suppression of mRNA expression and production of TNF-α, IL-6, IL-12p40 and IL-23 cytokines in psoriasis patients.